Cargando…
Diagnostic accuracy of DNA-based SDC2 methylation test in colorectal cancer screening: a meta-analysis
BACKGROUND: A growing body of research suggests that methylated genes can be used as early diagnostic markers for cancer. Some studies on methylated Syndecan 2 (SDC2) have shown that it has a great diagnostic ability in colorectal cancer. This meta-analysis was aimed to estimate the diagnostic perfo...
Autores principales: | Wang, Lixing, Liu, Yu, Zhang, Duohan, Xiong, Xiaoliang, Hao, Tingting, Zhong, Lili, Zhao, Yinlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235166/ https://www.ncbi.nlm.nih.gov/pubmed/35754025 http://dx.doi.org/10.1186/s12876-022-02395-7 |
Ejemplares similares
-
Methylation of SDC2/TFPI2 and Its Diagnostic Value in Colorectal Tumorous Lesions
por: Zhang, Lianglu, et al.
Publicado: (2021) -
Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test
por: Liu, Yan-Mei, et al.
Publicado: (2023) -
MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma
por: Zhong, Lili, et al.
Publicado: (2022) -
Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021) -
Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial
por: Kim, Chang Woo, et al.
Publicado: (2021)